Mental Health

MidCentral DHB is reminding women, partners, friends and whānau of the harmful impact that alcohol can have on unborn babies during pregnancy. September, the ninth month of the year, is Fetal Alcohol Spectrum Disorder awareness...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has signed an agreement with Auckland University of Technology (AUT). It will see Helius working with AUT academics and doctoral students, researching and developing advanced medicinal cannabis products. The announcement follows...

Stigma and discrimination against people with mental distress or illness is still very much a problem and people’s negative view of those with a mental illness often comes from a lack of understanding. People...

Pharmac is pleased to confirm that there will be no change in primidone tablets, a treatment used for the management of seizures and epilepsy. In June Pharmac put out a consultation on the supply of an...

MidCentral DHB (MDHB) will run its first low-sensory vaccination clinic on Thursday 16 September, 2021, at the Milson Community Centre in Palmerston North. This clinic offers a vaccination opportunity for those who have sensory needs,...

Mental health experts are warning the extended lockdown could have a severe and immediate impact on those battling addictions to food, alcohol, drugs and smoking. Addictions counsellor Leanne French says while lockdowns are an essential...

The NZ Drug Foundation is calling for donations to help them distribute a life-saving medication they have been spending years calling for. The organisation has set up a Givealittle page to help fund the distribution of...

New Zealand’s over 3,500 practising pharmacists need to urgently familiarise themselves with medicinal cannabis. Patient enquiries and demand are set to surge when Kiwi-made products come onto the market later this year, says one...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe. It allows the company to begin manufacturing locally made medicines for New Zealand...

University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis. Dr Ryan Ward (left), of the Department of Psychology, says he and a team of researchers have been...